Cooper Companies
This article was originally published in The Gray Sheet
Executive Summary
Federal judge fines the company more than $3 mil. on July 15 for seven counts of mail and wire fraud. The company says it must pay $1.8 mil. over three years and a restitution payment of $1.3 mil. due within 30 days. Cooper and former co-chairman Gary Singer were convicted of insider trading-related criminal charges in January ("The Gray Sheet" Jan. 17, p. 16); Cooper says that Singer's sentencing will occur "at a later date." Cooper also has "negotiated a settlement" of a November 1992 civil suit filed by the Securities and Exchange Commission against the firm, Singer; and several other parties for insider trading and manipulation of a Cooper debenture's trading price to avoid an interest rate reset. The company has agreed to "permanent injunctions against violation of certain provisions of the federal securities laws and against employment of any members of the Singer family." The SEC agreement also includes a $1.6 mil. disgorgement and a $1.2 mil. civil penalty, which is "reduced by the amounts of the restitution and fine" in the federal court's sentencing, leaving a $311,308 disgorgement payment
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.